<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: The Wnt signaling pathway is required for maintenance of the intestinal epithelia; blocking this pathway reduces the proliferative capacity of the intestinal stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>However, aberrant Wnt signaling leads to <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the roles of the Wnt pathway in homeostasis of the intestinal epithelium and during <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> in human cells and mice </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We performed chromatin immunoprecipitation (ChIP) with DNA microarray analysis (ChIP-on-chip) to identify genes regulated by Wnt signaling in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells Colo320, DLD1, LS174T, and SW480 </plain></SENT>
<SENT sid="4" pm="."><plain>Formation of <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> was induced in C57BL/6J mice using azoxymethane and <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Intestinal tissues from these mice, as well as Apc(+/Min) and Apc(CKO/CKO)/Lgr5-EGFP-IRES-CreERT2 mice, were analyzed by immunohistochemistry and in situ hybridization </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: We identified promoter regions of 960 genes that interacted with the Wnt pathway nuclear effector T-cell factor 4 in 4 different human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>-derived cell lines; 18 of these promoters were present in <z:hpo ids='HP_0000001'>all</z:hpo> chromatin precipitates </plain></SENT>
<SENT sid="7" pm="."><plain>Wnt signaling up-regulated a member of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor superfamily called TROY </plain></SENT>
<SENT sid="8" pm="."><plain>Levels of TROY <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> were increased in human cells with deficiencies in the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) gene and in cells stimulated with the Wnt3a ligand </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of Troy was significantly up-regulated in neoplastic tissues from mice during intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Lineage tracing experiments revealed that Troy is produced specifically by fast-cycling intestinal stem cells </plain></SENT>
<SENT sid="11" pm="."><plain>TROY associated with a unique marker of these cells, leucine-rich repeat-containing G-protein coupled receptor (LGR) 5 </plain></SENT>
<SENT sid="12" pm="."><plain>In organoids established from the intestinal crypts, Troy suppressed signaling mediated by R-spondin, a Wnt <z:chebi fb="4" ids="48705">agonist</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: TROY is up-regulated in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines and in <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumors</z:e> in mice </plain></SENT>
<SENT sid="14" pm="."><plain>It functions as a negative modulator of the Wnt pathway in LGR5-positive stem cells </plain></SENT>
</text></document>